Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 2001 Oct 2;127(12):751–754. doi: 10.1007/s004320100283

No effect of thromboxane A2 on the attachment of tumor cell lines MDA MB 231, DU145, and U937 to the basement membrane in an in-vitro model.

A Kleber 1, R Hartmann 1, J Jose 1
PMCID: PMC12164659  PMID: 11768616

Abstract.

Purpose: A broad body of evidence indicates the involvement of P450 TxA2 (thromboxane A2 synthetase) in tumor metastasis formation. A distinct function of the enzyme in this multistep process, however, is still unknown. Therefore the effect of TxA2 (thromboxane A2) on tumor cell adhesion to the basement membrane, a key event in metastasis formation, was investigated. Methods: A wide variety of compounds designed in our work group and identified as P450 TxA2 inhibitors were applied to several P450 TxA2-positive tumor cell lines to test their influence on tumor cell adhesion. For this purpose an in-vitro basement membrane adhesion model with the matrix gel preparation Matrigel was used. Results: Most of the P450 TxA2 inhibitors tested had no effect on cell adhesion. Although two compounds significantly reduced tumor cell adhesion in a concentration-dependent manner, this was not related to P450 TxA2 inhibition. Conclusion: These data indicate that TxA2 might not be involved in the attachment of tumor cell lines to the basement membrane.

Keywords: P450 TxA2 Inhibitors Metastasis Tumor cell adhesion Basement membrane

Footnotes

Electronic Publication


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES